These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9625737)

  • 1. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
    Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
    Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
    King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
    Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
    Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
    Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7.
    Luch A; Kudla K; Seidel A; Doehmer J; Greim H; Baird WM
    Carcinogenesis; 1999 May; 20(5):859-65. PubMed ID: 10334204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations induced by (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells.
    Mahadevan B; Dashwood WM; Luch A; Pecaj A; Doehmer J; Seidel A; Pereira C; Baird WM
    Environ Mol Mutagen; 2003; 41(2):131-9. PubMed ID: 12605383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts.
    Jiang H; Shen YM; Quinn AM; Penning TM
    Chem Res Toxicol; 2005 Feb; 18(2):365-74. PubMed ID: 15720144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytochrome P450- and peroxidase-dependent metabolic activation of the potent carcinogen dibenzo[a,l]pyrene in human cell lines: formation of stable DNA adducts and absence of a detectable increase in apurinic sites.
    Melendez-Colon VJ; Luch A; Seidel A; Baird WM
    Cancer Res; 1999 Apr; 59(7):1412-6. PubMed ID: 10197604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.
    Ralston SL; Seidel A; Luch A; Platt KL; Baird WM
    Carcinogenesis; 1995 Dec; 16(12):2899-907. PubMed ID: 8603462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
    Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldo-keto reductase- and cytochrome P450-dependent formation of benzo[a]pyrene-derived DNA adducts in human bronchoalveolar cells.
    Ruan Q; Gelhaus SL; Penning TM; Harvey RG; Blair IA
    Chem Res Toxicol; 2007 Mar; 20(3):424-31. PubMed ID: 17295519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
    Melendez-Colon VJ; Luch A; Seidel A; Baird WM
    Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human cytochrome p450 1b1 further clarifies its role in the activation of dibenzo[a,l]pyrene in cells in culture.
    Mahadevan B; Luch A; Atkin J; Haynes M; Nguyen T; Baird WM
    J Biochem Mol Toxicol; 2007; 21(3):101-9. PubMed ID: 17623886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.
    Kleiner HE; Vulimiri SV; Reed MJ; Uberecken A; DiGiovanni J
    Chem Res Toxicol; 2002 Feb; 15(2):226-35. PubMed ID: 11849049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the species-specific biotransformation of dibenzo[a,l]pyrene.
    Schober W; Luch A; Soballa VJ; Raab G; Stegeman JJ; Doehmer J; Jacob J; Seidel A
    Chem Biol Interact; 2006 May; 161(1):37-48. PubMed ID: 16581046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
    Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
    Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.